Skip to content

Clinical trials

Recruiting Atherosclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Status: Recruiting Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20103
20111
20121
20141
20155
20161
20171
20183
20193
20205
20215
20224
202319
202419
202532
202631

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting136

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong4
National Heart, Lung, and Blood Institute (NHLBI)4
Novartis Pharmaceuticals4
Seoul National University Bundang Hospital4
VA Office of Research and Development4
Eli Lilly and Company3
Massachusetts General Hospital3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
Assistance Publique - Hôpitaux de Paris2
Beijing Inno Medicine Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis136
Cardiovascular Diseases32
Coronary Artery Disease30
Diabetes Mellitus, Type 213
Peripheral Arterial Disease11
Dyslipidemias10
Inflammation9
Stroke9
Acute Coronary Syndrome8
Carotid Artery Diseases8

Trials

Showing 26 to 50 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.